ANPEP and cancer: Although NGR tripeptide sequence is currently the least investigated angiogenesis-connected agent, the ever-increasing importance of APN/CD13 in association with cancer-related processes, diagnostics or as a prognostic biomarker and therapeutic target brings NGR motif and its derivatives into the priority of today’s science [3].